Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis
- 1 January 1994
- journal article
- definition of-treatment-groups
- Published by Wiley in Annals of Neurology
- Vol. 36 (S1), S95-S96
- https://doi.org/10.1002/ana.410360721
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosisNeurology, 1993
- Epidemiology, education, and the ecology of Alzheimer's diseaseNeurology, 1993
- The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosisBrain, 1993
- The pathological evolution of multiple sclerosisNeuropathology and Applied Neurobiology, 1992
- Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: A randomized, double‐blinded, placebo‐controlled clinical trialAnnals of Neurology, 1990
- Systemic lymphoblastoid interferon therapy in chronic progressive multiple Sclerosis. I. Clinical and MRI evaluationNeurology, 1990
- The lesion of multiple sclerosisNeurology, 1989
- Serial magnetic resonance scanning in multiple sclerosis: A second prospective study in relapsing patientsAnnals of Neurology, 1989
- Magnetic Resonance Imaging in the Assessment of Disease Activity in Multiple SclerosisCanadian Journal of Neurological Sciences, 1988
- MRI in the diagnosis of MSNeurology, 1988